Safety Standards for Protection against Ionizing Radiation Article 2
The terms used in the Standards are defined as follows:1.Nuclide refers to a species of atom characterized by its neutron number, proton number and nuclear energy state.2.External exposure refers to body exposure due to irradiation by ionizing radiation from outside the body.3.Internal exposure refers to exposure due to irradiation by ionizing radiation arising from the intake of radioactive material.4.Activity refers to the number of spontaneous disintegrations occurring in a certain amount of radionuclides at a given time. The special name for the unit of activity is becquerel (Bq). One (1) spontaneous disintegration per second is one (1) becquerel.5.Dose refers to the radiation energy or its equivalent absorbed by material. (1) Absorbed dose refers to the mean energy imparted by radiation per unit mass of material. The special name for the unit of absorbed dose is gray (Gy). One (1) joule imparted per kilogram of mass is one (1) gray. (2) Dose equivalent refers to the product of the absorbed dose of body tissue or organ multiplied by a quality factor.The special name for the unit of dose equivalent is sievert (Sv). The quality factors used for radiation protection are seen in Schedule I-1(1). (3) Personal dose equivalent refers to the dose equivalent in soft tissue at an appropriate depth below a specified point on the body from external exposure. The relevant depth is 10 mm for strongly penetrating radiation, 0.07 mm for weakly penetrating radiation and 3 mm for the lens of the eye. The special name for the unit of personal dose equivalent is sievert. (4) Organ dose refers to the average absorbed dose in a unit mass of the tissue or organ. The special name for the unit of organ dose is gray. (5) Equivalent dose refers to the sum of the products of organ doses and their corresponding radiation weighting factors. The special name for the unit of equivalent dose is sievert. The radiation weighting factors are seen in Table I-1 of Schedule I-1(2). (6) Committed equivalent dose refers to the integration of equivalent dose rate in a particular tissue or organ following an intake of radioactive material over a time period. The period of integration is 50 years for those of age over 17. For those 17 or younger, the integration will be taken to age 70. The special name for the unit of committed equivalent dose is sievert. (7) Effective dose refers to the sum of the products of equivalent doses and their corresponding tissue weighting factors in all the exposed tissues and organs of the body. The special name for the unit of effective dose is sievert. The tissue weighting factors are seen in Table I-2 of Schedule I-2. (8) Committed effective dose refers to the sum of the products of committed equivalent doses and their corresponding tissue weighting factors for all the exposed tissues and organs of the body. The special name for the unit of committed effective dose is sievert. (9) Collective effective dose refers to the sum of effective doses received by a specific group of population exposed to a certain radiation source. It also means the product of the total number of population exposed to a certain radiation source and the average effective dose of individuals in the population. The special name for the unit of collective effective dose is man-sievert. 6.Reference man refers to an idealized adult representing an aggregation of human physical and physiological characteristics proposed by the International Commission on Radiological Protection (ICRP) for the purpose of radiation protection assessment.7.Annual limit on intake (ALI) refers to the intake of a given radionuclide in one (1) year by the reference man that would result in (1) a committed effective dose of 50 mSv, or (2) a committed equivalent dose of 500 mSv to any tissue or organ,whichever is the smaller.8.Derived air concentration (DAC) refers to the derived concentration of a given radionuclide in a cubic meter of air. If a reference man breathes in air with such a concentration for two thousand hours (2000 h) while doing light work, the intake would amount to one (1) ALI.9.The health effects of radiation are categorized as follows: (1) Deterministic effect: referring to an effect of functional loss of the tissue or organ, whose degree of severity increases in proportion to the magnitude of the dose received. A threshold dose may exist for this type of effect. (2) Stochastic effect: referring to an effect of carcinogenesis and heredity, whose probability of occurrence increases in proportion to the magnitude of the dose received, and is independent of its severity. There is no threshold dose for the occurrence of this type of effect.10.As low as reasonably achievable (ALARA) Observing the ALARA means making every reasonable effort to maintain, in a practical way, radiation exposure far below the dose limits of the Standards. Key principles are: (1) the activity must be consistent with the original permission; (2) the present state of technology, public health improvement, the economic benefits of safety, and societal and socioeconomic factors must be taken into account; and (3) the use of radiation must be in the public interests.11.Critical group refers to a group of people (1) representing the general public; (2) who receive rather uniform exposure from a known radiation source or a group of radiation sources; and (3) whose members have received the maximum dose.12.Human body tissue equivalent sphere (ICRU sphere) refers to a sphere of 300 millimeters in diameter made of tissue equivalent material with a density of 1 mg.mm-3 and a mass composition of 76.2% oxygen, 11.1% carbon, 10.1% hydrogen and 2.6% nitrogen.Schedule I Weighting Factors used in Radiation Protection.PDFSchedule I Weighting Factors used in Radiation Protection.doc
中文原文 游離輻射防護安全標準第2條
本標準用詞定義如下:
一、核種:指原子之種類,由核內之中子數、質子數及核之能態區分之。
二、體外曝露:指游離輻射由體外照射於身體之曝露。
三、體內曝露:指由侵入體內之放射性物質所產生之曝露。
四、活度:指一定量之放射性核種在某一時間內發生之自發衰變數目,其單位為貝克,每秒自發衰變一次為一貝克。
五、劑量:指物質吸收之輻射能量或其當量。
(一)吸收劑量:指單位質量物質吸收輻射之平均能量,其單位為戈雷,一千克質量物質吸收一焦耳能量為一戈雷。
(二)等效劑量:指人體組織或器官之吸收劑量與射質因數之乘積,其單位為西弗,射質因數依附表一之一(一)規定。
(三)個人等效劑量:指人體表面定點下適當深度處軟組織體外曝露之等效劑量。
對於強穿輻射,為十毫米深度處軟組織;對於弱穿輻射,為○‧○七毫米深度處軟組織;眼球水晶體之曝露,為三毫米深度處軟組織,其單位為西弗。
(四)器官劑量:指單位質量之組織或器官吸收輻射之平均能量,其單位為戈雷。
(五)等價劑量:指器官劑量與對應輻射加權因數乘積之和,其單位為西弗,輻射加權因數依附表一之一(二)規定。
(六)約定等價劑量:指組織或器官攝入放射性核種後,經過一段時間所累積之等價劑量,其單位為西弗。
一段時間為自放射性核種攝入之日起算,對十七歲以上者以五十年計算;對未滿十七歲者計算至七十歲。
(七)有效劑量:指人體中受曝露之各組織或器官之等價劑量與各該組織或器官之組織加權因數乘積之和,其單位為西弗,組織加權因數依附表一之二規定。
(八)約定有效劑量:指各組織或器官之約定等價劑量與組織加權因數乘積之和,其單位為西弗。
(九)集體有效劑量:指特定群體曝露於某輻射源,所受有效劑量之總和,亦即為該特定輻射源曝露之人數與該受曝露群組平均有效劑量之乘積,其單位為人西弗。
六、參考人:指用於輻射防護評估目的,由國際放射防護委員會提出,代表人體與生理學特性之總合。
七、年攝入限度:指參考人在一年內攝入某一放射性核種而導致五十毫西弗之約定有效劑量或任一組織或器官五百毫西弗之約定等價劑量兩者之較小值。
八、推定空氣濃度:為某一放射性核種之推定值,指該放射性核種在每一立方公尺空氣中之濃度。
參考人在輕微體力之活動中,於一年中呼吸此濃度之空氣二千小時,將導致年攝入限度。
九、輻射之健康效應區分如下:(一)確定效應:指導致組織或器官之功能損傷而造成之效應,其嚴重程度與劑量大小成比例增加,此種效應可能有劑量低限值。
(二)機率效應:指致癌效應及遺傳效應,其發生之機率與劑量大小成正比,而與嚴重程度無關,此種效應之發生無劑量低限值。
十、合理抑低:指盡一切合理之努力,以維持輻射曝露在實際上遠低於本標準之劑量限度。
其原則為:(一)須符合原許可之活動。
(二)須考慮技術現狀、改善公共衛生及安全之經濟效益以及社會與社會經濟因素。
(三)須為公共之利益而利用輻射。
十一、關鍵群體:指公眾中具代表性之人群,其對已知輻射源及曝露途徑,曝露相當均勻,且此群體成員劑量為最高者。
十二、人體組織等效球:指直徑為三百毫米,密度為每立方毫米一毫克之球體,其質量組成為:(一)氧:百分之七十六‧二。
(二)碳:百分之十一‧一。
(三)氫:百分之十‧一。
(四)氮:百分之二‧六。
一、核種:指原子之種類,由核內之中子數、質子數及核之能態區分之。
二、體外曝露:指游離輻射由體外照射於身體之曝露。
三、體內曝露:指由侵入體內之放射性物質所產生之曝露。
四、活度:指一定量之放射性核種在某一時間內發生之自發衰變數目,其單位為貝克,每秒自發衰變一次為一貝克。
五、劑量:指物質吸收之輻射能量或其當量。
(一)吸收劑量:指單位質量物質吸收輻射之平均能量,其單位為戈雷,一千克質量物質吸收一焦耳能量為一戈雷。
(二)等效劑量:指人體組織或器官之吸收劑量與射質因數之乘積,其單位為西弗,射質因數依附表一之一(一)規定。
(三)個人等效劑量:指人體表面定點下適當深度處軟組織體外曝露之等效劑量。
對於強穿輻射,為十毫米深度處軟組織;對於弱穿輻射,為○‧○七毫米深度處軟組織;眼球水晶體之曝露,為三毫米深度處軟組織,其單位為西弗。
(四)器官劑量:指單位質量之組織或器官吸收輻射之平均能量,其單位為戈雷。
(五)等價劑量:指器官劑量與對應輻射加權因數乘積之和,其單位為西弗,輻射加權因數依附表一之一(二)規定。
(六)約定等價劑量:指組織或器官攝入放射性核種後,經過一段時間所累積之等價劑量,其單位為西弗。
一段時間為自放射性核種攝入之日起算,對十七歲以上者以五十年計算;對未滿十七歲者計算至七十歲。
(七)有效劑量:指人體中受曝露之各組織或器官之等價劑量與各該組織或器官之組織加權因數乘積之和,其單位為西弗,組織加權因數依附表一之二規定。
(八)約定有效劑量:指各組織或器官之約定等價劑量與組織加權因數乘積之和,其單位為西弗。
(九)集體有效劑量:指特定群體曝露於某輻射源,所受有效劑量之總和,亦即為該特定輻射源曝露之人數與該受曝露群組平均有效劑量之乘積,其單位為人西弗。
六、參考人:指用於輻射防護評估目的,由國際放射防護委員會提出,代表人體與生理學特性之總合。
七、年攝入限度:指參考人在一年內攝入某一放射性核種而導致五十毫西弗之約定有效劑量或任一組織或器官五百毫西弗之約定等價劑量兩者之較小值。
八、推定空氣濃度:為某一放射性核種之推定值,指該放射性核種在每一立方公尺空氣中之濃度。
參考人在輕微體力之活動中,於一年中呼吸此濃度之空氣二千小時,將導致年攝入限度。
九、輻射之健康效應區分如下:(一)確定效應:指導致組織或器官之功能損傷而造成之效應,其嚴重程度與劑量大小成比例增加,此種效應可能有劑量低限值。
(二)機率效應:指致癌效應及遺傳效應,其發生之機率與劑量大小成正比,而與嚴重程度無關,此種效應之發生無劑量低限值。
十、合理抑低:指盡一切合理之努力,以維持輻射曝露在實際上遠低於本標準之劑量限度。
其原則為:(一)須符合原許可之活動。
(二)須考慮技術現狀、改善公共衛生及安全之經濟效益以及社會與社會經濟因素。
(三)須為公共之利益而利用輻射。
十一、關鍵群體:指公眾中具代表性之人群,其對已知輻射源及曝露途徑,曝露相當均勻,且此群體成員劑量為最高者。
十二、人體組織等效球:指直徑為三百毫米,密度為每立方毫米一毫克之球體,其質量組成為:(一)氧:百分之七十六‧二。
(二)碳:百分之十一‧一。
(三)氫:百分之十‧一。
(四)氮:百分之二‧六。